Evolving Paradigms in the SCLC Treatment Landscape

Expert oncologists review updates in the treatment of small cell lung cancer that were presented at key conferences in 2022 and discuss data in the context the current treatment landscape.

EP. 1: Current Strategies in Diagnosis and Classification of Small Cell Lung Cancer

July 31st 2023

Expert oncologists Laurent Greiller, MD, and Christian Grohé, MD, make introductions and review the current paradigm for small cell lung cancer diagnosis and classification.

EP. 2: Small Cell Lung Cancer: What is the Role of Biomarker Testing?

July 31st 2023

Shared insight on the early but evolving role of biomarker testing in patients diagnosed with extensive- or limited-stage small cell lung cancer.

EP. 3: Real-World Data and Observed AEs With Frontline Chemo IO Therapy in SCLC

August 14th 2023

Laurent Greiller, MD, and Christian Grohé, MD, consider real-world data and adverse events observed with frontline chemoimmunotherapy in small cell lung cancer.

EP. 4: Novel and Emerging Frontline Treatment Strategies in SCLC

August 14th 2023

Before closing out their first module, expert oncologists consider novel treatment strategies and agents in the frontline setting of stage small cell lung cancer.

EP. 5: Overview of Frontline Treatment Options in Small Cell Lung Cancer

September 1st 2023

Moving on to discuss the treatment armamentarium in small cell lung cancer, expert oncologists consider current standards for frontline therapy.

EP. 6: Small Cell Lung Cancer: What is the Role of IO Therapy in the Frontline Setting?

September 1st 2023

A brief review of the role that immunotherapy agents play in the frontline management of patients with small cell lung cancer.

EP. 7: Overview of Second-Line Treatment Options in SCLC

September 15th 2023

Expert oncologists Laurent Greiller, MD, and Christian Grohé, MD, reflect on the current state of second-line treatment options for patients with small cell lung cancer.

EP. 8: Clinical Data With Lurbinectedin in Small Cell Lung Cancer

September 15th 2023

Key opinion leaders share a focused discussion on lurbinectedin and its evolving role in small cell lung cancer following frontline therapy.

EP. 9: The Evolving Treatment Landscape of Small Cell Lung Cancer

September 22nd 2023

Closing out their program on small cell lung cancer management, Laurent Greiller, MD, and Christian Grohé, MD, highlight what excites them most about the evolving treatment paradigm.